noom and glp-1 expands its range with 'microdose' package Noom GLP-1 Access and Transparency

doi: 10.1210/jcem.85.10.6855 11 FujitaYYanagimachiTTakedaYHonjoJTakiyamaYAbikoAet al

While the contribution of weight loss remains unclear, this study, alongside emerging preclinical data from rodent models, suggests that GLP-1 medicines may offer efficacy in inflammation-driven diseases independent of the amelioration of metabolic dysfunction

That would be expected, given that obesity and excess weight are risk factors for heart attack and stroke

The combination has to be screened for phentermines cardiovascular contraindications and topiramates renal and cognitive effects, plus the additive nausea risk of GLP-1 plus topiramate

So, it was $2,300, now its $50 and the $1,300 doesnt cover a whole month

Our treatments are prescribed by licensed providers, tailored to your goals, and sourced only from trusted, certified pharmacies